Clinical Trials Browser

Recruiting × HR+/HER2- Breast Cancer × Clear all

NCT07492641 2026-06-03

KANDELA-302

Phase 3 Recruiting

HR+/HER2- Breast Cancer

NCT06998407 2026-05-04

AVZO-023-1001

Phase 1/2 Recruiting

HR+/HER2- Breast Cancer

NCT06860529 2025-06-23

Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast Cancer

Phase 2 Recruiting

HR+/HER2- Breast Cancer